Compare DexCom, Inc. (DXCM) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Sunrun Inc — how do they compare? DexCom, Inc. trades at $77.6 (market cap $28.06B), while Sunrun Inc trades at $12.13 (market cap $3.05B). The key difference: DexCom, Inc. is far larger — about 9.2× Sunrun Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | RUN | |
|---|---|---|
Market Cap | $28.06B | $3.05B |
Sector | Health | Technology |
52-Week High | $89.53 | $21.41 |
52-Week Low | $54.84 | $9.07 |
Enterprise Value | $27.03B | $17.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Sunrun (RUN) trades at $12.13, down 5.09% over 24 hours, with a bearish technical signal from moving averages. The company shows strong profitability with a 17.88% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights a major partnership with Tesla and Renew Home to create a 16-gigawatt virtual power plant, positioning the company to capitalize on AI data center power demand.
The outlook is mixed; analyst consensus is bullish with a $16.27 price target, but negative operating cash flow and high debt-to-asset ratio of 70.76% pose risks. Upside depends on successful execution of new initiatives and improved cash generation, while volatility may persist amid market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
